Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808067636> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- W2808067636 abstract "Background Despite the growing body of evidence, the proper use of ultrasound (US) in monitoring disease activity still needs better understanding. 1,2 As an objective measure, US could prevent overtreatment in situations of overestimation of clinical disease activity, such as fibromyalgia, present in up to 20% of patients with rheumatoid arthritis (RA). 3–5 Objectives To verify how ultrasound (US) could impact rheumatoid arthritis (RA) treatment decision in real life when fibromyalgia (FM) was also present. Methods A retrospective cohort study was performed from 2011 through 2016, including RA patients with FM. Patients were grouped according to US examination (Group DAS28: never performed US examination; Group US: at least one US exam). RA was considered active if DAS28 ≥3.2 in Group DAS28 or PD ≥2 in any single joint in Group US. Results Out of 230 RA patients, 22 women with concomitant FM (Group DAS28=10 and Group US=12) were seen in 280 visits from 2011 through 2016. DAS28 was 4.4 (2.5–6.3) vs. 4.0 (2.0–5.0) (p=0,592) in Groups DAS28 and US, respectively. DMARD treatment was escalated in 12.9% of visits in Group DAS28 versus 8.2% in Group US (p=0.791) (table 2). The relative risk (RR) for DMARD escalation in Group US compared to Group DAS28 was 1.08 (95%CI 0.60–1.95). However, in 74% of visits in Group US, DMARD was escalated despite a negative US result. In a theoretical scenario where US result oriented treatment decision, DMARD was escalated in 3.6% of visits in Groups DAS28 and US, respectively (table 1). Also, in this US-based scenario, the RR for DMARD escalation in Group US compared to Group DAS28 was 0.39 (0.19–0.83). The proportion of visits with US evaluation increased over time, nonetheless the level of agreement between US synovitis (PD ≥2) and DMARD escalation decreased (figure 1). Despite indicating US examination more frequently, rheumatologists did not base their DMARD escalation decision on PD synovitis. Conclusions In this real-life study of RA patients with FM, the growing use of US for evaluating RA activity over time was associated with an increasing discordance between US result and clinical judgement. When clinical judgement and US findings were discordant, RA treatment decision was mostly based on clinical judgement. If US result oriented treatment decision, DMARD escalation risk would be 61% smaller. References [1] Dale J, et al. Ann Rheum Dis. 2016;75(6):1043–50. [2] Haavardsholm EA, et al. BMJ2016;354:i4205. [3] Ranzolin A, et al. Arthritis Rheum. 2009;61(6):794–800. [4] Chakr RM, et al. Rev Bras Reumatol2016. doi:10.1016/j.rbr.2016.11.004 [5] Lage-Hansen PR, et al. Scand J Rheumatol2015. doi:10.3109/03009742.2015.1046484:1-4 Acknowledgements This study was funded by Hospital de Clinicas de Porto Alegre. Disclosure of Interest None declared" @default.
- W2808067636 created "2018-06-21" @default.
- W2808067636 creator A5000574655 @default.
- W2808067636 creator A5013168375 @default.
- W2808067636 creator A5032935573 @default.
- W2808067636 creator A5078750653 @default.
- W2808067636 creator A5078825821 @default.
- W2808067636 creator A5080783485 @default.
- W2808067636 date "2018-06-01" @default.
- W2808067636 modified "2023-10-05" @default.
- W2808067636 title "FRI0588 Ultrasound could have prevented dmard escalation in rheumatoid arthritis with fibromyalgia" @default.
- W2808067636 doi "https://doi.org/10.1136/annrheumdis-2018-eular.2538" @default.
- W2808067636 hasPublicationYear "2018" @default.
- W2808067636 type Work @default.
- W2808067636 sameAs 2808067636 @default.
- W2808067636 citedByCount "0" @default.
- W2808067636 crossrefType "proceedings-article" @default.
- W2808067636 hasAuthorship W2808067636A5000574655 @default.
- W2808067636 hasAuthorship W2808067636A5013168375 @default.
- W2808067636 hasAuthorship W2808067636A5032935573 @default.
- W2808067636 hasAuthorship W2808067636A5078750653 @default.
- W2808067636 hasAuthorship W2808067636A5078825821 @default.
- W2808067636 hasAuthorship W2808067636A5080783485 @default.
- W2808067636 hasBestOaLocation W28080676361 @default.
- W2808067636 hasConcept C126322002 @default.
- W2808067636 hasConcept C1862650 @default.
- W2808067636 hasConcept C2777575956 @default.
- W2808067636 hasConcept C2777831278 @default.
- W2808067636 hasConcept C2779384505 @default.
- W2808067636 hasConcept C71924100 @default.
- W2808067636 hasConcept C72563966 @default.
- W2808067636 hasConceptScore W2808067636C126322002 @default.
- W2808067636 hasConceptScore W2808067636C1862650 @default.
- W2808067636 hasConceptScore W2808067636C2777575956 @default.
- W2808067636 hasConceptScore W2808067636C2777831278 @default.
- W2808067636 hasConceptScore W2808067636C2779384505 @default.
- W2808067636 hasConceptScore W2808067636C71924100 @default.
- W2808067636 hasConceptScore W2808067636C72563966 @default.
- W2808067636 hasLocation W28080676361 @default.
- W2808067636 hasOpenAccess W2808067636 @default.
- W2808067636 hasPrimaryLocation W28080676361 @default.
- W2808067636 isParatext "false" @default.
- W2808067636 isRetracted "false" @default.
- W2808067636 magId "2808067636" @default.
- W2808067636 workType "article" @default.